Neoleukin Therapeutics, Inc.
SEC Filing List
NLTX CIK: 0001404644
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 3/A | Amendment to the Initial statement of be... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| 4/A | Amendment to Statement of changes in ben... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| 4/A | Amendment to Statement of changes in ben... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| 4/A | Amendment to Statement of changes in ben... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| 8-K | Current report filing | Neurogene Inc. | 06/08/2026 | ||
| 8-K | Current report filing | Neurogene Inc. | 06/04/2026 | ||
| 8-K | Current report filing | Neurogene Inc. | 05/12/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Neurogene Inc. | 05/12/2026 | ||
| 4 | Statement of changes in beneficial owner... | Cvijic Christine Mikail | Neurogene Inc. | 05/08/2026 | |
| 4 | Statement of changes in beneficial owner... | Shafer Christina | Neurogene Inc. | 05/07/2026 | |
| No record found. | |||||
| Load More | |||||
